Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment

Detalles Bibliográficos
Autores principales: Jiang, Tao, Jia, Qingzhu, Fang, Wenfeng, Ren, Shengxiang, Chen, Xiaoxia, Su, Chunxia, Zhang, Li, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403829/
https://www.ncbi.nlm.nih.gov/pubmed/32564494
http://dx.doi.org/10.1002/ctm2.109
_version_ 1783567018409066496
author Jiang, Tao
Jia, Qingzhu
Fang, Wenfeng
Ren, Shengxiang
Chen, Xiaoxia
Su, Chunxia
Zhang, Li
Zhou, Caicun
author_facet Jiang, Tao
Jia, Qingzhu
Fang, Wenfeng
Ren, Shengxiang
Chen, Xiaoxia
Su, Chunxia
Zhang, Li
Zhou, Caicun
author_sort Jiang, Tao
collection PubMed
description
format Online
Article
Text
id pubmed-7403829
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74038292020-08-06 Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment Jiang, Tao Jia, Qingzhu Fang, Wenfeng Ren, Shengxiang Chen, Xiaoxia Su, Chunxia Zhang, Li Zhou, Caicun Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-06-20 /pmc/articles/PMC7403829/ /pubmed/32564494 http://dx.doi.org/10.1002/ctm2.109 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Jiang, Tao
Jia, Qingzhu
Fang, Wenfeng
Ren, Shengxiang
Chen, Xiaoxia
Su, Chunxia
Zhang, Li
Zhou, Caicun
Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
title Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
title_full Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
title_fullStr Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
title_full_unstemmed Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
title_short Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
title_sort pan‐cancer analysis identifies tert alterations as predictive biomarkers for immune checkpoint inhibitors treatment
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403829/
https://www.ncbi.nlm.nih.gov/pubmed/32564494
http://dx.doi.org/10.1002/ctm2.109
work_keys_str_mv AT jiangtao pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment
AT jiaqingzhu pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment
AT fangwenfeng pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment
AT renshengxiang pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment
AT chenxiaoxia pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment
AT suchunxia pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment
AT zhangli pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment
AT zhoucaicun pancanceranalysisidentifiestertalterationsaspredictivebiomarkersforimmunecheckpointinhibitorstreatment

Ejemplares similares